Skip to main content
Clinical Trials/KCT0001055
KCT0001055
Recruiting
未知

Genetic Biomarker Research for Personalized Therapy of Chorioretinal Neovascular Diseases

Inje University Busan Paik Hospital0 sites1,000 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the eye and adnexa
Sponsor
Inje University Busan Paik Hospital
Enrollment
1000
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Observational Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • (1\) Patients written consent to participate in research
  • (2\) Patients written consent to genetic test and Research agreement
  • (3\) Adults more than 50 years old
  • (4\) Macular degeneration caused by chorioretinal neovascularization patients and diabetic retinopathy patients diagnosed with slit lamp examination, fundus photography, optical coherence tomography(OCT), fluorescein angiography or indocyanine angiographic.
  • (5\) Macular degeneration caused by chorioretinal neovascularization patients and diabetic retinopathy patients not diagnosed with slit lamp examination, fundus photography, optical coherence tomography(OCT), fluorescein angiography or indocyanine angiographic.

Exclusion Criteria

  • 1\) Patients with soft drusen or atrophic macular degeneration not accompanied by chorioretinal neovascularization
  • 2\) difficult Patients to observe the fundus because of moderate to severe cataract
  • 3\) The possibility of pregnancy in patients.
  • However, No surgery for female infertility of childbearing age can participate in a clinical trial after the interview pregnancy
  • 4\) The Case legally, mentally unsuitable for participation in a clinical trial if the investigator

Outcomes

Primary Outcomes

Not specified

Similar Trials